60 Degrees Pharmaceuticals SXTP Q1 2026 earnings
Reported May 15, 2026 · Before market open
Revenue$162.1KMiss by $117.9K
EPS-$1.28Miss by $0.52
Revenue estimate$280.0K
EPS estimate-$0.76
Next report
Aug 12, 2026 (In 2 weeks)Revenue estimate$185.0K
EPS estimate-$0.74
Versus estimates
Revenue
Diluted EPS
Ask the moment 60 Degrees Pharmaceuticals reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did 60 Degrees Pharmaceuticals report Q1 2026 earnings?
- 60 Degrees Pharmaceuticals (SXTP) reported Q1 2026 earnings on May 15, 2026 before market open.
- What were 60 Degrees Pharmaceuticals's Q1 2026 revenue and EPS?
- 60 Degrees Pharmaceuticals reported revenue of $162.1K and eps of $-1.28 for Q1 2026.
- Did 60 Degrees Pharmaceuticals beat estimates in Q1 2026?
- Revenue missed the consensus estimate of $280.0K by $117.9K. EPS missed the consensus estimate of $-0.76 by $0.52.
- How did 60 Degrees Pharmaceuticals's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 0.9% from $163.6K a year earlier and eps grew 17.9% from $-1.56.
- Where can I find 60 Degrees Pharmaceuticals's Q1 2026 SEC filings?
- You can read the 10-Q periodic report (0001554855-26-001058) directly on SEC EDGAR. The filing index links above go to sec.gov.